Standardized, modular and automated manufacturing processes to ensure product quality, safety and consistency.
Collect peripheral blood mononuclear cells (PBMCs) from the patient.
Wash the collected cells and mix them with immunomagnetic beads for cell selection.
Isolate and enrich T cells using immunomagnetic bead technology.
Cryopreserve the purified T cells.
Activate T cells using immunomagnetic beads.
Genetically modify T cells using a lentiviral vector.
Expand CAR-T cells in a wave bioreactor to achieve the required cell dose.
Harvest, wash, formulate and cryopreserve the CAR-T cells.
Perform release testing before infusion to ensure product quality.
Infuse CAR-T cells under the supervision of trained healthcare professionals.
99% Manufacturing Success Rate
Proven manufacturing process with high batch-to-batch consistency.
Modular and flexible workflows that support scalable manufacturing.
Immunomagnetic cell selection enables high purity and high viability.
Low-temperature control throughout critical process steps to preserve cell viability.
Manufactured in compliance with cGMP standards to ensure product quality and patient safety.